BIOMAT Database Logo BIOMAT Database Logo

The effect of platinum cytostatics on delayed-type hypersensitivity in mice. 1989

P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Charles University, Faculty of Pharmacy, Hradec Králové, Czechoslovakia.

The effect of cisplatin, carboplatin, oxoplatin, and iproplatin on delayed-type hypersensitivity in mice was studied. Comparing the equitoxic doses, which were close to therapeutic dosages, we found a greater inhibition of delayed-type hypersensitivity in the second-generation platinum complexes than in cisplatin. This inhibition occurred mainly when these drugs were applied after sensitization. This phenomenon might be explained by the antimitotic action of platinum cytostatics. The lower toxicity of second-generation platinum drugs was not accompanied by a corresponding decrease of immunotoxicity.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016190 Carboplatin An organoplatinum compound that possesses antineoplastic activity. cis-Diammine(cyclobutanedicarboxylato)platinum II,Blastocarb,CBDCA,Carboplat,Carbosin,Carbotec,Ercar,JM-8,NSC-241240,Nealorin,Neocarbo,Paraplatin,Paraplatine,Platinwas,Ribocarbo,JM 8,JM8,NSC 241240,NSC241240

Related Publications

P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Effect of histamine on delayed-type hypersensitivity in mice.
August 1986, Immunopharmacology,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Immunoregulatory effect of antibody on delayed-type hypersensitivity in mice.
January 1989, International archives of allergy and applied immunology,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Immunomodulating effect of neurotropin on delayed type hypersensitivity response in mice.
August 1988, Japanese journal of pharmacology,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
[The effect of bacterial lipopolysaccharides on the delayed type hypersensitivity reaction in mice].
January 1984, Mikrobiologicheskii zhurnal,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
March 1978, European journal of immunology,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Regulatory mechanism of delayed-type hypersensitivity in mice. II. Effect of suppressor cells on the development of memory cells for delayed-type hypersensitivity.
May 1980, Cellular immunology,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Delayed-type hypersensitivity models in mice.
January 2013, Methods in molecular biology (Clifton, N.J.),
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
[Effect of radiation on tumor-specific delayed-type hypersensitivity (DTH) response in mice].
May 1989, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Delayed type hypersensitivity for penicillin in mice. I. Induction and characterization of delayed type hypersensitivity for penicillin in mice.
April 1981, The Journal of antibiotics,
P Jílek, and J Dvoráková, and J Turecková, and J Procházková
Lung delayed-type hypersensitivity in stressed mice.
April 1984, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
Copied contents to your clipboard!